These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 24716987)
1. Importance of volumetric measurement processes in oncology imaging trials for screening and evaluation of tumors as per response evaluation criteria in solid tumors. Vemuri RC; Jarecha R; Hwi KK; Gundamaraju R; Maruthikanth A; Kulkarni A; Reddy S Asian Pac J Cancer Prev; 2014; 15(5):2375-8. PubMed ID: 24716987 [TBL] [Abstract][Full Text] [Related]
2. Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment. Morse B; Jeong D; Ihnat G; Silva AC Abdom Radiol (NY); 2019 Feb; 44(2):766-774. PubMed ID: 30196362 [TBL] [Abstract][Full Text] [Related]
3. [RECIST and the radiologist]. Cervera Deval J Radiologia; 2014; 56(3):193-205. PubMed ID: 22902252 [TBL] [Abstract][Full Text] [Related]
4. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases. Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565 [TBL] [Abstract][Full Text] [Related]
5. Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST. Fenerty KE; Folio LR; Patronas NJ; Marté JL; Gulley JL; Heery CR BMC Cancer; 2016 Aug; 16(1):672. PubMed ID: 27553491 [TBL] [Abstract][Full Text] [Related]
6. RECIST 1.1-Update and clarification: From the RECIST committee. Schwartz LH; Litière S; de Vries E; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; Seymour L Eur J Cancer; 2016 Jul; 62():132-7. PubMed ID: 27189322 [TBL] [Abstract][Full Text] [Related]
7. ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases. Goyal N; Apolo AB; Berman ED; Bagheri MH; Levine JE; Glod JW; Kaplan RN; Machado LB; Folio LR J Digit Imaging; 2017 Jun; 30(3):275-286. PubMed ID: 28074302 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation. Hillman SL; An MW; O'Connell MJ; Goldberg RM; Schaefer P; Buckner JC; Sargent DJ J Clin Oncol; 2009 Jul; 27(19):3205-10. PubMed ID: 19414682 [TBL] [Abstract][Full Text] [Related]
9. Pitfalls in RECIST Data Extraction for Clinical Trials: Beyond the Basics. Abramson RG; McGhee CR; Lakomkin N; Arteaga CL Acad Radiol; 2015 Jun; 22(6):779-86. PubMed ID: 25794800 [TBL] [Abstract][Full Text] [Related]
10. Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel. Sonpavde G; Pond GR; Templeton AJ; Fandi A; Tombal B; Rosenthal M; Armstrong AJ; Petrylak DP Eur Urol; 2016 Jun; 69(6):980-3. PubMed ID: 26497922 [TBL] [Abstract][Full Text] [Related]
11. Response criteria in oncologic imaging: review of traditional and new criteria. Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927 [TBL] [Abstract][Full Text] [Related]
12. Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis. Taieb S; Saada-Bouzid E; Tresch E; Ryckewaert T; Bompas E; Italiano A; Guillemet C; Peugniez C; Piperno-Neumann S; Thyss A; Maynou C; Clisant S; Penel N; Eur J Cancer; 2015 Jan; 51(2):202-9. PubMed ID: 25499439 [TBL] [Abstract][Full Text] [Related]
13. [Response criteria for malignant melanoma: RECIST and irRC]. Spiro J; Maintz D; Persigehl T Radiologe; 2015 Feb; 55(2):127-35. PubMed ID: 25637198 [TBL] [Abstract][Full Text] [Related]